| Accession |
PRJCA025163 |
| Title |
A Clinical Study of GC012F Injection in High-risk, Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma |
| Relevance |
Medical |
| Data types |
clinical study
|
| Organisms |
Homo sapiens
|
| Description |
This is a single-arm, single-center, open-label clinical study to evaluate the safety and efficacy of GC012F in high-risk, transplant eligible patients with NDMM 22 evaluable subjects were dosed. |
| Sample scope |
Multiisolate |
| Release date |
2024-04-10 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
siyu
huang (siyu.huang@gracellbio.com)
|
| Organization |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
| Submission date |
2024-04-10 |
